Interleukin-1β Blockers
- Name
- Interleukin-1β Blockers
- Accession Number
- DBCAT005687
- Description
Not Available
- Drugs
Drug Drug Description Canakinumab An interleukin-1β blocker used to treat Periodic Fever Syndromes such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Familial Mediterranean Fever (FMF), and also to treat active Systemic Juvenile Idiopathic Arthritis (SJIA). - Drugs & Drug Targets
Drug Target Type Canakinumab Interleukin-1 beta target